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Abstract: Since the time Covid-19 was discovered in Southeast Asia, around 2.5 million people have been 
infected and more than 54 thousand have died by early March 2021. Even though ASEAN members have 
followed most of the WHO recommendations to deal with Covid-19, cases are still liable to increase. 
Therefore, vaccine utilization is the best chance which people believe in to fight the pandemic for now. 
However, the vaccine’s availability and distribution are a dilemma for the ASEAN member countries. 
Therefore, this article aims to determine the possibility of ASEAN’s role in creating equal access to the 
Covid-19 vaccine for everyone. According to the juridical normative research, ASEAN is committed to 
protect and promote human rights and to realize the Sustainable Development Goals (SDGs). On that basis, 
the organization tends to play an important role in Covid-19 vaccination in Southeast Asia by cooperating 
with its partners to research and create the required vaccine. 
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1. Introduction  
Since the discovery of Covid-19 in late 2019, multiple aspects such as public health, social 
activity, and the economy have been threatened. Moreover, the disease has spread to 
223 countries or different regions since it was declared as a pandemic in March 2020 by 
WHO.1 As of mid-March 2021, more than 119 million people have been infected and over 
2.6 million have died. Globally, most of the states introduced new policies and regulations 
to prevent Covid-19 transmission, for example, the practice of quarantine, physical 
distancing, travel restrictions, and lockdowns, but2 these are not enough effective tools. 
In Southeast Asia, the first case of Covid-19 was discovered in Thailand on 13th January 
2020, and it increases onwards. Until 3rd March 2021, there were around 2.5 million 
Covid-19 cases in the ASEAN region with more than 54 thousand deaths recorded.3 
Although some ASEAN member states such as Vietnam, Malaysia, Thailand, and the 
Philippines implemented national lockdowns with different time ranges to suppress the 
 
1 World Health Organization. (2020). WHO Coronavirus (COVID-19) Dashboard, Available Online from: 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019. [Accessed, March 15, 2021] 
2 Forman, L., & Kohler, J. C. (2020). Global health and human rights in the time of COVID-19: Response, restrictions, 
and legitimacy. Journal of Human Rights, 19(5), 547–556. https://doi.org/10.1080/14754835.2020.1818556.  
3 ASEAN Biodaspora Virtual Center. (2021). Risk Assessment for International Dissemination of COVID-19 to the 
ASEAN Region (Vol. 2021). https://asean.org/storage/COVID-19_Report-of-ASEAN-BioDiaspora-Regional-Virtual-
Center_26February2021.pdf. [Accessed March 15, 2021.] 
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disease’s spread. Meanwhile, Indonesia preferred Large Scale Social Restriction (PSBB) 
policy to the national lockdown.4 The ASEAN members have also followed WHO 
recommendations in handling Covid-19, for instance, social and physical distancing, 
wearing a mask, rapid testing, contact tracing, and quarantine for suspected cases. These 
measures were proven to be insufficient in stopping the spread, therefore the best and 
safest vaccine is believed as the only hope to combat Covid-19. 
At the end of 2020, the mass-produced Covid-19 vaccine in United States, Russia, and 
China has already been distributed globally. Provided that vaccine development is a good 
chance in resisting this pandemic, yet the distribution is a significant problem that must 
be faced. Without global and coordinated efforts to ensure the vaccine is accessible for 
every person, priority access becomes a concern as it tends to be defined according to 
pay ability, nationality, and residence state, besides evidence-based needs.5 Hence, the 
distribution process creates a dilemma for all authorities in the world, both within and 
inter-states. The state government is under pressure to obtain the effective and safe 
vaccine rapidly to meet its people’s needs, which is liable to cause the disrepair of other 
citizens’ health. Contrarily, the pandemic is a global phenomenon that has affected 
almost everyone. For effectiveness and international law, the state government needs to 
respect other citizens’ health.6 As the main entity in international law, international 
organizations either at the universal or regional level, need to participate in confirming 
the fairness of vaccine distribution. 
Specifically in Southeast Asia, can ASEAN play a role in encouraging solidarity among 
states and agree to guarantee equal access towards the safe and effective vaccine? The 
Economist Intelligence Unit (EIU) estimated diverse time is needed to attain a 
comprehensive vaccination. Singapore is predicted to achieve this purpose in early 2022, 
while Myanmar, Laos, Cambodia, the Philippines, and Indonesia tend to require at least 
4 years.7 The ASEAN has to function in ensuring an equal vaccine distribution as it is in 
line with a collective effort of the member states encouraging the organization which is 
inclusive, people-centered, and with no one left behind. Hence, the attainment of the 
Sustainable Development Goals (SDGs) is facilitated.8 
Several articles examine the aforementioned disease, one of which is connecting Covid-
19 with the evolution that tends to occur to human rights specifically in the health 
aspect.9 Human rights implementation to manifest access to the required vaccine 
 
4 Rahayu, S., & Sulistiadi, W. (2020). The Effectiveness of COVID-19 Countermeasure Policy Implementation in 
Seven ASEAN Countries. Journal of Indonesian Health Policy and Administration, 5(2), 43–49. 
https://doi.org/10.7454/ihpa.v5i2.3880.  
5 United Nations Human Rights. (2020). Human Rights and Access to Covid-19 Vaccines. In Human Rights at The 
Heart of Response. Nomos Verlagsgesellschaft mbH & Co. KG. https://doi.org/10.5771/9783845273945.  
6 Bogdandy, A. von and P. A. V. (2020). The Role of International Law in Vaccinating Against Covid-19: Appraising 
the Covax Initiative (No. 2020–46; MPIL Research Paper Series). 
7 Strangio, Sebastian. (2021). Southeast Asia COVID-19 Vaccine Coverage a Long Way Off: Report, Available Online 
from: https://thediplomat.com/2021/01/southeast-asia-covid-19-vaccine-coverage-a-long-way-off-report/.  
[Accessed March 20, 2021] 
8 Zen, F., Komazawa, O., Gross, J., Menon, J., Zen, F., Komazawa, O., & Gross, J. (2019). Leave No One Behind. In 
Kimura, F., V. Anbumozhi, H. Nishimura. (eds.). Transforming and Deepening the ASEAN Community (Issue May, pp. 
147–162). Jakarta: ERIA. 
9 Forman, L., & Kohler, J. C. (2020). Global health and human rights in the time of COVID-19: Response, restrictions, 
and legitimacy. Journal of Human Rights, 19(5), 547–556. https://doi.org/10.1080/14754835.2020.1818556.  
Hasanuddin Law Rev. 7(2): 119-132 
121 
 
predicted the development of new global governance through the law is needed.10 
ASEAN members’ responses toward the disease have been discussed by other sources. 
Based on media the statement and policy research from each of the ASEAN members, 
this organization is believed to have a constructive role in formulating a response towards 
the coordinated pandemic.11 The comparative national policy on handling Covid-19 
provided by states in Southeast Asia has shown a new perspective of maintaining the 
relationship between government and citizens to implement the most effective policy for 
reducing the death rate.12 This article focuses on the possibility of ASEAN’s role in creating 
equal access to Covid-19 vaccination in Southeast Asia. It is reviewed from ASEAN’s role 
as an international organization, namely commitment towards the fulfillment of human 
rights and SDGs. 
 
2. Method 
A juridical normative research method was used, which is based on the positive law and 
it is also relevant to ASEAN’s role in fulfilling human rights. Analysis was conducted using 
the descriptive method which explains human rights’ principles fulfillment through 
vaccination by the international organization, to achieve SDGs target, specifically on 
health and welfare strength or SDGs-3. This article used a legal approach that emphasizes 
more on international law, either soft or hard. Data were collected from kinds of 
literature, to obtain relevant law instruments along with secondary research sources, 
such as books, national or international journals, and more, then analyzed qualitatively. 
 
3. Human Rights and SDGs Call for Covid-19 Vaccines. 
3.1.  Covid-19 Vaccines in the Human Rights Context 
Commitments to propose and protect human rights, as well as respect fundamental 
freedoms universally from states around the world are already mentioned in Articles 1 
and 3 of the United Nations (UN) Charter. These were followed up by United Nations 
through 2 (two) mechanisms. Firstly, the United Nations human rights system has a treaty 
body created by its Charter, one of which is the Human Rights Council. This is known as 
the United Nations Charter-based Mechanism. Secondly, another one known as the 
Treaty-based system covers international agreements concerning human rights agreed 
among states, such as the Universal Declaration on Human Rights (UDHR) and 
International Bill of Rights, etc.13 UN treaty bodies and Charter-based the mechanism 
 
10 Gostin, L. O., Karim, S. A., & Mason Meier, B. (2020). Facilitating Access to a COVID-19 Vaccine through Global 
Health Law. Journal of Law, Medicine and Ethics, 48(3), 622–626. https://doi.org/10.1177/1073110520958892.  
11 Djalante, R., Nurhidayah, L., Minh, H. Van, Thi, N., Phuong, N., Mahendradhata, Y., Trias, A., Lassa, J., & Ann, M. 
(2020). COVID-19 and ASEAN responses: Comparative policy analysis. Progress in Disaster Science, 8(January), 1–12. 
https://doi.org/http://dx.doi.org/10.1016/j.pdisas.2020.100129.  
12 Rahayu, S., & Sulistiadi, W. (2020). The Effectiveness of COVID-19 Countermeasure Policy Implementation in 
Seven ASEAN Countries. Journal of Indonesian Health Policy and Administration, 5(2), 43–49. 
https://doi.org/10.7454/ihpa.v5i2.3880. 
13 Kaufman, R. E. (2011). Using Human Rights Mechanisms of the United Nations to Advance Economic Justice. 
Journal of Poverty Law and Policy, 1(6), 259–267. 
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provide every individual with various possibilities to claim for government and institution 
protection on the international level. 
Amidst the Covid-19 pandemic, the rights to life become a concern for every action 
performed by the states related to fighting the disease. Article 6 of the International 
Covenant on Civil and Political Rights (ICCPR) become the basis emergence of state 
obligation towards human rights. Therefore, states need to carry out the right action and 
maximize all resources to resolve Covid-19 to protect many lives and fulfill the right to 
health,14 since the disease is recognized as a global public health threat impacting 
negatively to the quality of humanity as known. 
Fundamental rights of health and social protection are recognized internationally and 
also stated in Article 25 UDHR. In line with the declaration of WHO in 1946, the enjoyment 
of the highest attainable health standard is one of the fundamental human rights without 
distinction of race, religion, political belief, and economic or social condition.15 Moreover, 
Article 12 paragraph 1 of Covenant on Economic, Social, and Cultural Rights (ICESCR) 
emphasizes that states’ parties need to recognize everyone’s right to the enjoyment of 
the highest attainable physical and mental health standard. 
Article 12 paragraph 2, point c ICECSR stated that states parties need to take a certain 
step to achieve the full realization of the right to health as well as the prevention, 
treatment, and control of epidemic, endemic, occupational, and other diseases. Human 
Rights Council gives some annotations concerning the Rights to the Highest Attainable 
Health Standard, which is called comment 14, namely:16 
a) To ensure reproductive, maternal (prenatal as well as post-natal), and child health 
care;  
b) To provide immunization against the major infectious diseases occurring in the 
community;  
c) To take measures to prevent, treat, and control epidemic and endemic diseases;  
d) To provide education and access to information concerning the main health 
problems in the community, including methods of preventing and controlling them;  
e) To provide appropriate training for health personnel, including education on health 
and human rights. 
Measures such as mask utilization and lockdown were already implemented by states to 
prevent the spread of Covid-19, but they have been ineffective. Therefore, the most 
dependable resistance to the disease is a vaccine. The availability of a safe, effective, 
accessible, and free vaccine for everyone is needed to end this pandemic,17 which tends 
to save lots of life in line with the fundamental human rights to life. Scientifically, 
immunization is the best preventive tool and the most important element for the right to 
 
14  Saunders, J. (2020). Covid-19 and Human Rights. Oxfam Discussion Paper. 1 – 48.  
15  Institute for Human Rights and Business. (2020). Respecting Human Rights in the Time of the COVID-19 Pandemic: 
Examining Companies’ Responsibilities for Workers and Affected Communities. Available Online at 
https://www.ihrb.org/focus-areas/covid-19/report-respecting-.  
16  Saunders, J. (2020). Covid-19 and Human Rights. Oxfam Discussion Paper. 1 – 48. 
17  Oxfam Discussion Paper. 1 – 48. 
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the Highest Attainable Health Standard18 as already stated above in the General 
Comment of the Human Rights Council 14, point b. 
The Covid-19 vaccine is supposed to be considered as a global public good, besides a 
commodity that is traded in the market.19 Therefore, its accessibility need not be based 
on someone or richer states’ purchase ability in the decrement of the poorest. This 
vaccine is a form of human rights fulfillment obtaining benefits from scientific progress, 
which has become the state’s obligation to ensure the scientific progress is felt by 
everybody.20 The United Nations Special Rapporteur concerning the right to health 
concluded that state is mandatory to “do all they reasonably can to make sure that 
existing medicines are available in sufficient quantities”.21 For the sake of health 
fulfillment rights, states have an important role to immediately and effectively 
accomplish universal access to vaccines. 
Covid-19 vaccine tends to be considered in relation with human rights perspective, once 
the availability of safe and effective vaccine is provided by the states with the following 
conditions:22 
1. Available: The produced vaccine is widely and sufficiently distributed by states. 
2. Accessible: States need to eliminate obstacles to the process of vaccine distribution 
for vulnerable and marginalized populations, make sure the vaccine is affordable, 
in good condition, and equipped with all the information that is needed. 
3. Acceptable: The vaccination process needs to be performed with the individual’s 
consent and adjusted with the society’s tradition. 
Of Sufficient Quality: The vaccine needs to fulfill the requirement of being “scientifically 
and medically appropriate and of good quality”, to avoid fake vaccines, inadequate and 
ingenious health workers, and approved equipment. 
Non-discrimination principles need to be implemented by states as a form of paying 
attention to the vulnerable society. Also, the Covid-19 vaccine needs to reach the 
vulnerable categories such as women, indigenous people, beggars, LGBTQ groups, people 
with disabilities, and immigrants - especially stateless immigrants, minority society, and 
other marginalized groups.23 Article 1 of DUHAM stated that: “All human beings are born 
free and equal in dignity and rights”. The vaccine’s benefit tends to be effective when it 
is equally accessible for all states. A big risk is faced when there is one state or region that 
still lacks the Covid-19 vaccine. Therefore, those unable to conduct vaccination need to 
 
18 Gostin, L. O., Karim, S. A., & Mason Meier, B. (2020). Facilitating Access to a COVID-19 Vaccine through Global 
Health Law. Journal of Law, Medicine and Ethics, 48(3), 622–626. https://doi.org/10.1177/1073110520958892. 
19 United Nations Human Rights. (2020). Human Rights and Access to Covid-19 Vaccines. In Human Rights at The 
Heart of Response. Nomos Verlagsgesellschaft mbH & Co. KG. https://doi.org/10.5771/9783845273945.  
20 Committee on Economic Social and Cultural Rights (CESCR), General Comment No. 25 (2020) on science and 
economic, social and cultural rights (article 15 (1) (b), (2), (3) and (4) of the Covenant), para. 70.  
21 Gostin, L. O., Karim, S. A., & Mason Meier, B. (2020). Facilitating Access to a COVID-19 Vaccine through Global 
Health Law. Journal of Law, Medicine and Ethics, 48(3), 622–626. https://doi.org/10.1177/1073110520958892. 
22 Gostin, L. O., Karim, S. A., & Mason Meier, B. (2020). Facilitating Access to a COVID-19 Vaccine through Global 
Health Law. Journal of Law, Medicine and Ethics, 48(3), 622–626. https://doi.org/10.1177/1073110520958892. 
23 Nigam, Shalu. (2021). Ensuring Vaccine Equity, Erasing Vaccine Nationalism: Upholding the Human Rights and 
Justice Framework (April 15, 2021). Available at SSRN: https://ssrn.com/abstract=3827273 or 
http://dx.doi.org/10.2139/ssrn.3827273.  
P-ISSN: 2442-9880, E-ISSN: 2442-9899 
124 
 
obtain assistance from international entities as both developing and developed states are 
required to provide the vaccine.24 
The Covid-19 Vaccines Global Access (COVAX) mechanism, a product of partnership, is 
global cooperation to advance vaccine development and production, including attaining 
equitable distribution.25 In addition to ensuring provision to all countries, COVAX also 
aims to prepare vaccines at low prices. High-income countries buy vaccines from COVAX 
at an estimated average price of $11 per dose, while it is available at about $1.6 – 2.0 per 
dose for the low- and middle-income ones.26 In addition, several regional mechanisms 
have been presented, such as the Covid-19 African Vaccine Acquisition Task Team 
(AVATT) to support the African Vaccine Strategy and the Asia-Pacific Vaccine Access 
Facility.27 Although some progress is being made through COVAX and the direct 
distribution of overdosing vaccines between countries, efficient and equitable 
distribution globally cannot simply depend on donors’ goodwill and temporary 
solutions.28 Therefore, developing countries' governments urgently need to develop and 
produce sustainable long-term vaccines. 
Moreover, Covid-19 vaccination needs to be held transparently.29 Any kinds of 
information regarding production, ingredients, side effect and vaccine procurement 
budget have to be generally known. Such clear information helps society to respond to 
the government’s policy concerning vaccination programs. Article 19 Para (2) of ICCPR 
specifies that every individual shall have the right to freedom of expression; this right 
shall include freedom to seek, receive and impart information and ideas of all kinds, 
regardless of frontiers, either orally, in writing, or print, in the form of art, or through any 
media of his choice. 
The effective Covid-19 vaccine needs to be considered as a global public good,30 and all 
states ought to benefit from global cooperation. In an abnormal situation, any kind of 
state or company need not obtain an advantage from the circumstances. Hence, global 
governance is needed to ensure the Covid-19 vaccine is widely accessible and 
 
24 Nigam, Shalu. (2021). Ensuring Vaccine Equity, Erasing Vaccine Nationalism: Upholding the Human Rights and 
Justice Framework (April 15, 2021). Available at SSRN: https://ssrn.com/abstract=3827273 or 
http://dx.doi.org/10.2139/ssrn.3827273.  
25 Terzakis, K., & Maren Klein. (2021). SDG 17: Partnerships for the Goals. Policy Brief. 1 – 8. 
26 Wouters, O. J., Shadlen, K. C., Salcher-konrad, M., Pollard, A. J., Larson, H. J., Teerawattananon, Y., & Jit, M. 
(2021). Health Policy Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, 
and deployment. The Lancet, 397(10278), 1023–1034. https://doi.org/10.1016/S0140-6736(21)00306-8.  
27 OECD. (2021). Coronavirus (COVID-19) vaccines for developing countries: An equal shot at recovery. In OECD 
Policy Responses to Coronavirus (Issue February). https://www.oecd.org/coronavirus/policy-responses/coronavirus-
covid-19-vaccines-for-developing-countries-an-equal-shot-at-recovery-6b0771e6/#blocknotes-d7e2077.  
28 OECD. (2021). Access to COVID-19 vaccines: Global approaches in a global crisis. In OECD Policy Responses to 
Coronavirus (Issue March). https://www.oecd.org/coronavirus/policy-responses/access-to-covid-19-vaccines-global-
approaches-in-a-global-crisis-c6a18370/.  
29 Human Rights Watch. (2020). “Whoever Finds the Vaccine Must Share It” Strengthening Human Rights and 
Transparency around Covid-19 Vaccines. Report, (October 2020). 
https://www.hrw.org/sites/default/files/media_2020/10/globalvaccine1020_web.pdf.  
30 Nigam, Shalu. (2021). Ensuring Vaccine Equity, Erasing Vaccine Nationalism: Upholding the Human Rights and 
Justice Framework (April 15, 2021). Available at SSRN: https://ssrn.com/abstract=3827273 or 
http://dx.doi.org/10.2139/ssrn.3827273. 
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affordable.31 For affordability’s sake, increasing the capacity of low- and middle-income 
countries (LMIC) is necessary to produce vaccines. However, intellectual property rights 
(IPR) hampers vaccine access to LMICs. The new medicines are protected by patent law, 
so it restricts LMIC from producing the same vaccines. Intellectual Property Rights (IPR) 
provides exclusive rights for contriver, to facilitate the potential for monopoly.32 
International law governs the protection of patent universally, through the Paris 
Convention for the Protection of Industrial Property of 1883 and the Agreement on 
Trade-Related Aspects of Intellectual Property Rights (TRIPS), which also lies under the 
WTO Marrakech Accords.33 Article 27 para (1) states patents shall be available for any 
inventions, whether products or processes, in all fields of technology, provided that they 
are new, involve an inventive step, and are capable of industrial application. Being aware 
that patents tend to be an obstacle in realizing affordable access to Covid-19 health 
products, WHO and partners launched the Covid-19 Technology Access Pool (C-TAP) in 
May 2020. C-TAP is a potential center for global developers of health products for this 
disease, including vaccines to share their intellectual property rights, knowledge, and 
data and as well join the Solidarity all to Action. By this voluntary agreement, Covid-19 
Vaccine’s developers increase production through multiple manufacturers with non-
exclusive and transparent licenses.34 In this early stage of vaccination, international 
solidarity becomes an expectation both for low- and middle-income countries to access 
the Covid-19 vaccine. 
 
3.2.  Covid-19: New Guest in the Way to Realize the SDGs 
The 2030 agenda which is known as “Sustainable Development Goals (SDGs)” ratified in 
September 2015 by 193 United Nations member states after a prolonged negotiation 
among the governments for 3 (three) years since it was agreed in the UN Conference on 
Sustainable Development or Rio +20 in Rio de Janeiro, in June 2012.35 The 2030 Agenda 
for Sustainable Development offers a blueprint for prosperity and peace for the world 
and humans for now and the future. The accomplishment of this agenda tends to be 
determined by an achievement of 17 SDGs, which needs action from all states within the 
framework of a global partnership. United Nations’ members understand that to end 
poverty and other deprivations, they must go conjointly with a strategy that tends to 
improve health and education, reduce inequality, and encourage economic growth, while 
 
31 Gostin, L. O., Karim, S. A., & Mason Meier, B. (2020). Facilitating Access to a COVID-19 Vaccine through Global 
Health Law. Journal of Law, Medicine and Ethics, 48(3), 622–626. https://doi.org/10.1177/1073110520958892. 
32 Bogdandy, A. von and P. A. V. (2020). The Role of International Law in Vaccinating Against Covid-19: Appraising 
the Covax Initiative (No. 2020–46; MPIL Research Paper Series). 
33 World Health Organization, World Trade Organization and World Intellectual Property Organization. (2020). 
Promoting Access to Medical Technologies and Innovation (2nd ed.). WHO, WTO and WIPO. 
https://doi.org/10.30875/fa323700-en.  
34 World Health Organization. (2020). WHO Covid-19 Technology Access Pool. 
https://www.who.int/initiatives/covid-19-technology-access-pool. [Accessed June 13, 2021] 
35 Mukarram, M. (2020). Impact of COVID-19 on the UN Sustainable Development Goals (SDGs). Strategic Analysis, 
44(3), 253–258. https://doi.org/10.1080/09700161.2020.1788363.  
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overcoming climate change along with preserving the sea and forest.36 Here are the 
already agreed 17 goals:37 
1. SDG 1 : No Poverty 
2. SDG 2 : Zero Hunger 
3. SDG 3 : Good Health and Well-being 
4. SDG 4 : Quality Education 
5. SDG 5 : Gender Equality 
6. SDG 6 : Clear Water and Sanitation 
7. SDG 7 : Affordable and Clean Energy 
8. SDG 8 : Decent Work and Economic Growth 
9. SDG 9 : Industry, Innovation, and Infrastructure 
10. SDG 10: Reduce Inequality 
11. SDG 11: Sustainable Cities and Communities 
12. SDG 12: Responsible Consumption and Production 
13. SDG 13: Climate Action 
14. SDG 14: Life Below Water 
15. SDG 15: Life on Land 
16. SDG 16: Peace, Justice and Strong Institutions 
17. SDG 17: Partnerships to Achieve the Goals 
The achievement of these goals is affected by Covid-19 which is a global challenge, but 
each state has a different impact depending on the social-economic condition. Moreover, 
developing and small island states face some hardship. United Nations Department of 
Economic and Social Affairs predicted global remittent has decreased the cause of Covid-
19. Moreover, poor people are suffering because of this pandemic. In monetary terms, 
low- and middle-income states are experiencing a loss of $445 million.38 There are lots of 
acknowledgments that the disease is attacking those living with poverty. 
The pandemic has caused an immediate impact on the 17 SDG goals as mentioned above. 
One of them is SDG-1, namely “no poverty,” which is the most basic and most important 
thing in the SDGs39, however, Covid-19 has huge potential in increasing poverty 
universally at a rate of 420-580 million people, because the current economic stagnation 
is unavoidable. This is possibly the first escalation in global poverty since 1990.40 Covid-
19 has caused about 18 million ASEAN’s people to become poor, inclusive of 3 million in 
 
36 United Nations. (2015). The 17 Goals. Available Online from: https://sdgs.un.org/goals. [Accessed March 22, 
2021] 
37 United Nations. (2015). Take Action for the Sustainable Development Goals. 
https://www.un.org/sustainabledevelopment/sustainable-development-goals/. [Accessed March 25, 2021] 
38 Terzakis, K., & Maren Klein. (2021). SDG 17: Parnerships for the Goals. Policy Brief. 1 – 8.  
39 UNDP. (2020). Impact of COVID-19 on the Sustainable Development Goals: Pursuing the SDGs in a World 
Reshaped by COVID-19. https://sdgintegration.undp.org/sites/default/files/Impact_of_COVID-19_on_the_SDGs.pdf.  
40 Sumner, A., Hoy, C., & Ortiz-Juarez, E. (2020). Estimates of the impact of COVID-19 on global poverty. UNU WIDER 
Working Paper 2020/43, April 1–9. https://doi.org/10.35188/UNU-WIDER/2020/800-9.  
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extreme poverty41 which is the main reason for hunger in the world and it is counter-
productive to the second priority in SDGs (SDG-2). 
An effort to promote sustained, inclusive, and sustainable economic growth, full and 
productive employment, and decent work on SDG-8 in 2030 is liable to also face some 
obstacles. Foreign Direct Investment (FDI) fell by 40% in 2020, and the FDI flows in 2021 
is expected to decrease by a further 5-10%42.Even though, foreign investment ought to 
build resilient infrastructure, promote inclusive and sustainable industrialization, and 
foster innovation globally (SDG-9). Based on such data, it is estimated that 285 million 
people or around 80% from 4 (four) African states (Ethiopia, Malawi, Nigeria, and 
Uganda) have lost their livelihood because of Covid-19.43 This disease has also paralyzed 
the ASEAN economy through the following factors: firstly, lower global demand has 
decreased the organization’s exports. Secondly, the reduction of foreign direct 
investment (FDI) in the ASEAN region, and finally, the downturn in the number of foreign 
tourists to ASEAN is very drastic. Covid-19 has rendered over 30 million people in ASEAN 
unemployed, 44 thereby indicating its immediate impact on reducing inequality within 
and among countries (SDG-10). 
With that regard, the vaccine has become the main protection45 and a tool in stopping 
adverse effects of COVID-19 in all aspects especially to the SDGs. One of the most cost-
effective health-care to save lives and improve health and prosperity [SDGs] is through 
vaccinations. Annual vaccines save up to 2-3 million lives yearly and prevent countless 
disease cases.46 The accomplishment of vaccinations depends on accessibility as well as 
affordability.47 
An important factor capable of making vaccines accessible and affordable for all is a 
partnership. Hence, the Covid-19 vaccine should be produced based on SDGs principles 
that are “leaving no one behind” and “multi-stakeholder partnerships”. Participation 
from government, international organizations, corporations, societies, and individuals is 
needed to create the vaccines [SDG-14]. A holistic approach needs to be stressed to stop 
the current pandemic. 
 
 
41 Ing, Lili Yan. (2021). "Economic outlook 2021: Beware of prolonged recession". Click to read: 
https://www.thejakartapost.com/academia/2021/01/05/economic-outlook-2021-beware-of-prolonged-
recession.html., [Accessed June 5, 2021] 
42 Terzakis, K., & Maren Klein. (2021). SDG 17: Parnerships for the Goals. Policy Brief. 1 – 8. 
43 Kilic T, Michler J. (2020). Socio-Economic Impacts of COVID-19 in Four African Countries: Watch the Event 
Recording. Available at: https://www.worldbank.org/en/programs/lsms/brief/socioeconomic-impacts-of-covid-19-in-
four-african-countries-watch-the-event-recording. [Accessed March 19, 2021] 
44 Ing, Lili Yan. (2021). "Economic outlook 2021: Beware of prolonged recession". Click to read: 
https://www.thejakartapost.com/academia/2021/01/05/economic-outlook-2021-beware-of-prolonged-
recession.html., [Accessed June 5, 2021]. 
45 Seshaiyer, P., & McNeely, C. L. (2020). Challenges and Opportunities From COVID-19 for Global Sustainable 
Development. World Medical and Health Policy, 12(4), 443–453. https://doi.org/10.1002/wmh3.380.  
46 Gavi. (2020). “Sustainable Development Goals”. Available Online from:  https://www.gavi.org/our-
alliance/global-health-development/sustainable-development-goals. [Accessed March 26, 2021] 
47 Seshaiyer, P., & McNeely, C. L. (2020). Challenges and Opportunities From COVID-19 for Global Sustainable 
Development. World Medical and Health Policy, 12(4), 443–453. https://doi.org/10.1002/wmh3.380. 
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4. ASEAN for Equal Access to the Covid-19 Vaccines in Southeast Asia 
Viruses such as SARS-C0V-2 are the commonest biological entities on Earth, and they are 
transmitted from one person to another. Therefore, Covid-19 vaccine development and 
distribution need to be performed with good coordination. The most effective, 
sustainable, and decent response to overcome this global crisis is by also producing the 
vaccine based on all states’ solidarity. Furthermore, data and technology need to be 
transferred among states, international organizations, the private sector, and the 
government to support the campaign for a successful and inclusive global vaccination.48 
To further support this activity, global cooperation is required to create an effective 
vaccination that is beneficial to all nations.49 In Southeast Asia, ASEAN is expected to 
realize general access to the vaccine. 
The ASEAN has a high commitment concerning the promotion and attainment of SDGs, 
as well as human rights protection. At least those 2 indicators are enough to promote this 
organization’s function in ensuring vaccination is available for all societies in Southeast 
Asia. SDGs in the context of national development are already adopted by all ASEAN 
members which are fully committed to support and implement the 2030 Agenda and 
SDGs as part of efforts to stop poverty, inequity, and injustice. The ASEAN charter’s 
preamble confirmed that this organization is committed to ensuring “sustainable 
development for the benefit of the present and future generations and to place the 
peoples’ well-being, livelihood, and welfare at the centre of ASEAN community building 
process”.50 This commitment is difficult to fulfil because Covid-19 has constrained its 
progress through stagnancy or reversal of the developmental process. Consequently, 
once ASEAN wants to resume work on achieving SDGs, the disease needs to be stopped 
immediately, which tends to occur only when fair vaccination is implemented. 
The Covid-19 pandemic has a negative impact on the efforts targeted at fulfilling human 
rights in Southeast Asia. This includes initiating a right to health crisis, therefore human 
rights need to be positioned as a core focus or the basis of government response to the 
disease.51 The journey on countermeasures to be used still requires lots of works and 
casualties, not only in the ASEAN region but also globally. Continuous cooperation among 
different states is needed to protect everyone’s rights in this pandemic. The longer the 
crisis exists, the more human rights are restricted. Recently, vaccination is the biggest 
hope in stopping the spread of Covid-19. 
Covid-19 vaccination in Southeast Asia needs to be conducted based on non-
discrimination principles. Every individual is entitled to the benefit of the proposed 
vaccine, in line with article 9 paragraph 1 of the ASEAN Human Rights Declaration (AHRD), 
which states “every person has the right to enjoy the highest attainable standard of 
physical, mental and reproductive health, as well as basic and affordable health care 
 
48 United Nations Human Rights. (2020). Human Rights and Access to Covid-19 Vaccines. In Human Rights at The 
Heart of Response. Nomos Verlagsgesellschaft mbH & Co. KG. https://doi.org/10.5771/9783845273945. 
49 Moon, S., Rottingen, J. A., & Frenk, J. (2017). Global public goods for health: Weaknesses and opportunities in 
the global health system. Health Economics, Policy and Law, 12(2), 195–205. 
https://doi.org/10.1017/S1744133116000451.  
50 Secretary-general of ASEAN. (2007). The ASEAN Charter. Jakarta: ASEAN Secretariat.  
51 FORUM-ASIA. (2020). Human Rights in Southeast Asia in Times of Pandemic. Available at 
https://humanrightsinasean.info/wp-content/uploads/2020/09/LO-CovidASIAF3.pdf.  
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services, and obtain access to medical facilities”. This is why the organization needs to 
ensure that “no Southeast Asian country is left behind” on the vaccination. The problem 
encountered is that currently Covid-19 vaccine is not produced independently by the 
member states. 
The ASEAN has solid regional cooperation as confirmed in the preamble of its Charter. 
The member states already have a strong core to corporate and combat Covid-19 
together. Besides, the regional corporation has the potential to obtain support from 
partners such as ASEAN plus one and ASEAN plus Three. On 14th April 2020, In Vietnam, 
ASEAN leaders, along with President Xi Jinping, Prime Minister Shinzo Abe, and President 
Moon Jae-in met in the Special ASEAN Summit and52 the result was to act jointly and 
decisively to control the spread of Covid-19. They also agreed to strengthen public health 
cooperation and joint research regarding vaccine and anti-viral medicines, as well as to 
intensify public communication and reduce stigmatization and discrimination and create 
the required Covid-19 ASEAN Response Fund.53 
The international law obliges states to achieve the progressive realization of the rights 
protected by the Covenant, which includes the right to health.54 The WHO International 
Health Regulations also requires states “to collaborate, to any possible extent, in: (1) the 
detection and assessment of and response to events as provided. (2) The provision or 
facilitation of technical cooperation and logistical support, particularly in the 
development, strengthening and maintenance of the required public health capacities. 
(3) The mobilization of financial resources to facilitate their obligations’ implementation, 
and (4) the formulation of proposed laws and other legal and administrative provisions 
for the Regulations’ implementation.”55 ASEAN member states are also committed to 
enhancing partnerships for sustainable development through SDGs-17. Therefore, the 
best means for the organization to ensure equitable access to Covid-19 vaccines is 
through international cooperation and assistance, because international cooperation 
both globally and regionally is a key requirement for this purpose. 
A regional approach is required within the ASEAN framework, considering that COVAX 
has not yet provided the Covid-19 vaccine to low- and middle-income countries because 
the stocks are determined by donations from developed countries. The highest-income 
countries control 80% of the world's vaccines while the low-income ones only access 
10%.56 Therefore, the ASEAN members cannot only rely on donations or vaccines 
obtained at low prices through the COVAX scheme. But, the organization urgently needs 
to produce its vaccines with international assistance in some form, such as by technology 
transfer and sharing of knowledge and vaccine recipe. 
 
 
52 ASEAN. (2020). Declaration of the Special ASEAN Summit on Coronavirus Disease 2019 (COVID-19). Available at 
https://asean.org/storage/2020/04/FINAL-Declaration-of-the-Special-ASEAN-Summit-on-COVID-19.pdf.  
53 United Nations. (2020). The Impact of COVID-19 on South-East Asia. Policy Briefs, 1–29. 
54 Article 2.1 of The International Covenant on Economic, Social and Cultural Rights (ICESCR). 
55 Article 44.1 of the WHO International Health Regulation, https://www.who.int/ihr/publications/ 
9789241580496/en/.  
56 Nigam, Shalu. (2021). Ensuring Vaccine Equity, Erasing Vaccine Nationalism: Upholding the Human Rights and 
Justice Framework (April 15, 2021). Available at SSRN: https://ssrn.com/abstract=3827273 or 
http://dx.doi.org/10.2139/ssrn.3827273.  




In the name of human rights and Sustainable Development Goals, Covid-19 vaccination 
in Southeast Asia needs to be conducted equally. This is because the ASEAN has the 
potential to objectify, besides it is a regional organization that possesses robust 
cooperation. Furthermore, ASEAN cooperates with its partners such as ASEAN plus one 
and ASEAN plus three to carry out some research and produce Covid-19 vaccines. 
International law both hard and soft also requires inter-state cooperation, especially in 
facing the international nature of the pandemic. 
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